Outcomes associated with nesiritide administration for acute decompensated heart failure in the emergency department observation unit: A single center experience

Congestive Heart Failure

Volumn 15, Issue 3, 2009, Pages 103-107

  Styron, Joseph F ^a,b   Jois Bilowich, Preeti ^b   Tallman, Thomas ^b   Emerman, Charles ^c   Starling, Randall C ^b   Peacock, W Frank ^b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c METROHEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; GLYCERYL TRINITRATE; NESIRITIDE;

ACUTE HEART FAILURE; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; EMERGENCY WARD; FEMALE; HEART EJECTION FRACTION; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATION UNIT; OUTCOMES RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

AGED; CASE-CONTROL STUDIES; COHORT STUDIES; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEART FAILURE; HUMANS; LOGISTIC MODELS; MALE; NATRIURETIC AGENTS; NATRIURETIC PEPTIDE, BRAIN; ODDS RATIO; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 65749085345     PISSN: 15275299     EISSN: 17517133     Source Type: Journal    
DOI: 10.1111/j.1751-7133.2009.00065.x     Document Type: Article

References (20)

1. Massie BM, Shah NB. Evolving trends in epidemiologic factors of heart failure: Rationale for preventative strategies and comprehensive disease management. Am Heart J 1997;133(6):703-712.
2. American Heart Association. Heart Disease and Stroke Statistics: 2005 Update. Dallas, TX: American Heart Association; 2005.
3. Rame JE, Sheffield MA, Dries DL, et al. Outcomes after emergency department discharge with a primary diagnosis of heart failure. Am Heart J. 2001;142(4):714-719.
4. Peacock WF, Aponte JH, Craig MT, et al. Inpatient versus emergency department observation unit management of heart failure [abstract 180]. Ann Emerg Med. 1998;32(pt 2):S46-S47.
5. Peacock WF, Remer EE, Aponte J, et al. Effective observation unit treatment of decompensated heart failure. Congest Heart Fail. 2002;8:68-73.
6. Peacock WF, Albert NM. Patient outcome and costs following an acute heart failure (HF) management program in an emergency department (ED) observation unit (OU) [abstract 240]. J Heart Lung Transplant. 1999;18:92.
7. Peacock WF, Albert NM, Emerman CL, et al. Emergency department observation unit heart failure treatment protocol decreases adverse outcome rates [abstract 289]. J Card Fail. 1999;5(suppl 1):77.
8. Kosowsky JM, Gasaway MD, Hamilton CA, et al. Preliminary experience with an emergency department observation unit protocol for heart failure [abstract 33]. Acad Emerg Med. 2000;7:1171.
9. Publication Committee for the VMAC Investigators. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: A randomized controlled trial. JAMA. 2002;287:1531-1540.
10. Peacock WF 4th, Holland R, Gyamarthy R, et al. Observation unit treatment of heart failure with nesiritide: Results from the proaction trial. J Emerg Med. 2005;29(3): 243-252.
11. Zineh I, Schofield RS, Johnson JA. The evolving role of nesiritide in advanced or decompensated heart failure. Pharmacotherapy. 2003;23:1266-1280.
12. Peacock WF, Emerman CL, Silver MA. Nesiritide added to standard care favorably reduces systolic blood pressure compared with standard care alone in patients with acute decompensated heart failure. Am J Emerg Med. 2005;23:327-331.
13. Miller AH, Nazeer S, Pepe P, et al. Acutely decompensated heart failure in a county emergency department: A double-blind randomized controlled comparison of nesiritide versus placebo treatment. Ann Emerg Med. 2008;51(5):571-578.
14. Sackner-Bernstein JD, Skopicki HA, Aaronson KD. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation. 2005;111(12):1487-1491.
15. Sackner-Bernstein JD, Kowalski M, Fox M, et al. Short-term risk of death after treatment with nesiritide for decompensated heart failure: A pooled analysis of randomized controlled trials. JAMA. 2005;293(15):1900-1905.
16. Fonarow GC, Adams KF, Abraham WT, et al. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA. 2005;293:572-580.
17. Clinical Quality Improvement Network Investigators. Mortality risk and patterns of practice in 4606 acute care patients with congestive heart failure: The relative importance of age, sex, and medical therapy. Arch Intern Med. 1996;156:1669-1673.
18. Blackledge HM, Tomlinson J, Squire IB. Prognosis for patients newly admitted to hospital with heart failure: Survival trends in 12 220 index admissions in Leicestershire 1993-2001. Heart. 2003;89:615-620.
19. Ishii J, Cui W, Kitagawa F, et al. Prognostic value of combination of cardiac troponin T and B-type natriuretic peptide after initiation of treatment in patients with chronic heart failure. Clin Chem. 2003;49:2020-2026.
20. Clyde W, Yancy MD; On behalf of the Fusion II Investigators. The follow-up serial infusions of nesiritide for the management of patients with heart failure II (FUSION II). Presented at the "Late Breaker" Session of the American College of Cardiology, 56th Annual Scientific Session, March 24-27, 2007.